Becton, Dickinson and Company (BD) has secured the US Food and Drug Administration (FDA) 510(k) clearance for the Surgiphor 1,000ml antimicrobial irrigation system, designed for powered lavage.
Surgiphor 1,000ml is developed specifically for powered irrigation workflows in the operating room, marking an advance in standardising wound cleaning in surgical settings.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The system enables clinicians to mechanically loosen and remove debris and microorganisms from wounds during powered irrigation procedures.
It aims to simplify complex wound care by providing consistent performance and ease of use throughout various surgical interventions.
Delivered as a ready-to-use, sterile product, Surgiphor 1,000ml eliminates the requirement for manual mixing by hospital staff. This feature is intended to help hospitals meet international safety guidelines for wound cleaning while reducing preparation time in operating rooms.
The new configuration builds upon the existing Surgiphor portfolio, offering operating room teams a higher-volume option that integrates seamlessly with current powered irrigation setups.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe system is compatible with many established powered lavage devices and includes features such as a powered-device adapter, Y-connector to switch between saline and Surgiphor solutions, and a twist cap for manual application.
An integrated venting mechanism ensures smooth flow, while the collapsible bottle design aids evacuation and handling.
Surgiphor 1,000ml features a terminally sterile PVP-I solution available in multiple sizes and formats.
BD Surgery business worldwide president Rian Seger said: “This FDA clearance reinforces BD’s position as the global leader in surgical irrigation innovation. Surgiphor 1,000ml is a unique solution that provides the consistency and safety surgical teams expect from BD, allowing them to focus on what matters most: providing better, safer care for their patients.”
In January 2026, BD and Ypsomed announced an expansion of their partnership with the development of a 5.5ml version of the BD Neopak XtraFlow glass prefillable syringe.
